I like the sounds of this:
"and was a co-author of AAPS-sponsored Industry White Papers that were incorporated into FDA and EMA Guidance for Immunogenicity Assessment."
If anyone knows the path for FDA approval, it should be this guy.
The fact the they have a REAL product that is selling, made me give it a chance. I know it's a gamble, but sometimes great reward comes with great risk.
I'm just glad to see the price his holding up, that's all. I'll get more excited when it's closer to it's 52 week high. I won't go as far to say I trust the FDA, but who cares what I think anyway.
Just not today.
If they go it alone, and do get a orphan drug approval, wouldn't that make for a much bigger pop? More shares at such a low price is not a good sign for short term holders. I'm still buying in the belief they will spend this money wisely, and in shareholder interest.
Sentiment: Strong Buy
The SEC might want to look into the bloggers post. Because apparently only he knows they are reporting today. I'm taking more of a long term approach. Doubling down only on any good news. Like the balance sheet is indeed getting straighten out. Don't put all your eggs in one basket... Avoid the scammers, and pumpers with dates.
Geesh the pumpers are as faithfully blind as the bashers. I love how you quote me though, make me feel important. I get it you, REALLY REALLY like CVM.
This was released early this morning on their website: IMMUNOCELLULAR THERAPEUTICS BIO CEO 2015 - IMMUNOCELLULAR WILL NOT BE PRESENTING AT BIOCEO CONFERENCE AS ORIGINALLY PLANNED DUE TO FINANCING ACTIVITY.
Anyone know what financing activity they are talking about? Looks like no conference today.
Smart move, I'm just glad mine is a small position. I'm going to have to add to it now. Did they give any mention as to when they will make money off the new platform?
That was for a different stock. If it got on this board, it wasn't meant to. I've been in and out of CVM for almost 3 years. I just started taking a looking at ONCS, and might take a position. I get frustrated just like any other shareholder, no one likes losing money. I also like IMUC over NWBO, but there again, how much pain can one handle.
My hope is that the results are so good they don't need a conference call. If they beat the top and bottom line, what's there to talk about? It's a very small position. They have to be growing by now, with all the pans in the fire. Good luck to you as well.
Sentiment: Strong Buy
On it now, I see they turned a nice profit, and cost of revenue is down, always good. I hope they have a good outlook. My $6.18 might of been a little preemptive. I'm in now, and I'll just try and average out until good news comes again.